Search research articles
Contact Us
Filters
Showing results (1-10 of 109) with videos related to
Page
of 11
Sort By:
Zentralblatt Fur Gynakologie
|
March 2, 2002
[Treatment of endometrial carcinoma - evidence based criteria]
C Brumm, P A Fasching, M W Beckmann
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Biomarkers in Breast Cancer - An Update
M Schmidt, P A Fasching, M W Beckmann, et al.
Anticancer Research
|
January 12, 2007
Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer
D Skiba, G Mehlhorn, P A Fasching, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
October 21, 2005
[Prophylactic surgery of mammary and ovarian carcinoma]
M P Lux, M R Bani, P A Fasching, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 16, 2008
Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions
D Rauber, G Mehlhorn, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
June 2, 2015
Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology
C C Hack, N B M Hüttner, P A Fasching, et al.
Maturitas
|
March 28, 2007
Risk and risk assessment for breast cancer: molecular and clinical aspects
M W Beckmann, M R Bani, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
October 21, 2016
Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients
M Wallwiener, E Simoes, A N Sokolov, et al.
Der Pathologe
|
January 14, 2014
[Sebaceous breast carcinoma: report of a rare histological special subtype]
D L Wachter, C Rauh, E Wenkel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2023
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study
G Curigliano, K Dunton, M Rosenlund, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 109) with videos related to
Sort By:
Page
of 11
Zentralblatt Fur Gynakologie
|
March 2, 2002
[Treatment of endometrial carcinoma - evidence based criteria]
C Brumm, P A Fasching, M W Beckmann
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Biomarkers in Breast Cancer - An Update
M Schmidt, P A Fasching, M W Beckmann, et al.
Anticancer Research
|
January 12, 2007
Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer
D Skiba, G Mehlhorn, P A Fasching, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|
October 21, 2005
[Prophylactic surgery of mammary and ovarian carcinoma]
M P Lux, M R Bani, P A Fasching, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
July 16, 2008
Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions
D Rauber, G Mehlhorn, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
June 2, 2015
Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology
C C Hack, N B M Hüttner, P A Fasching, et al.
Maturitas
|
March 28, 2007
Risk and risk assessment for breast cancer: molecular and clinical aspects
M W Beckmann, M R Bani, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
October 21, 2016
Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients
M Wallwiener, E Simoes, A N Sokolov, et al.
Der Pathologe
|
January 14, 2014
[Sebaceous breast carcinoma: report of a rare histological special subtype]
D L Wachter, C Rauh, E Wenkel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2023
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study
G Curigliano, K Dunton, M Rosenlund, et al.
Page
of 11